BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33186670)

  • 1. The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease.
    Kahroba H; Ramezani B; Maadi H; Sadeghi MR; Jaberie H; Ramezani F
    Ageing Res Rev; 2021 Jan; 65():101211. PubMed ID: 33186670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
    Dinkova-Kostova AT; Kostov RV; Kazantsev AG
    FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
    Xiang Y; Song X; Long D
    Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
    Lee DH; Gold R; Linker RA
    Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuins and redox signaling interplay in neurogenesis, neurodegenerative diseases, and neural cell reprogramming.
    Mormone E; Iorio EL; Abate L; Rodolfo C
    Front Neurosci; 2023; 17():1073689. PubMed ID: 36816109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
    Denzer I; Münch G; Friedland K
    Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.
    Marchetti B
    Redox Biol; 2020 Sep; 36():101664. PubMed ID: 32863224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
    Esteras N; Dinkova-Kostova AT; Abramov AY
    Biol Chem; 2016 May; 397(5):383-400. PubMed ID: 26812787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases.
    Tyler SEB; Tyler LDK
    IBRO Neurosci Rep; 2023 Jun; 14():210-234. PubMed ID: 36880056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
    Sivandzade F; Prasad S; Bhalerao A; Cucullo L
    Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration.
    Goodfellow MJ; Borcar A; Proctor JL; Greco T; Rosenthal RE; Fiskum G
    Exp Neurol; 2020 Jun; 328():113247. PubMed ID: 32061629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
    Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
    Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes.
    Pistollato F; Canovas-Jorda D; Zagoura D; Bal-Price A
    Neurochem Int; 2017 Sep; 108():457-471. PubMed ID: 28627367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid β Peptide Compromises Neural Stem Cell Fate by Irreversibly Disturbing Mitochondrial Oxidative State and Blocking Mitochondrial Biogenesis and Dynamics.
    Ribeiro MF; Genebra T; Rego AC; Rodrigues CMP; Solá S
    Mol Neurobiol; 2019 Jun; 56(6):3922-3936. PubMed ID: 30225776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRF2: An emerging role in neural stem cell regulation and neurogenesis.
    Boorman E; Killick R; Aarsland D; Zunszain P; Mann GE
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):437-446. PubMed ID: 36272667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
    George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
    Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity.
    Casares L; Unciti-Broceta JD; Prados ME; Caprioglio D; Mattoteia D; Higgins M; Apendino G; Dinkova-Kostova AT; Muñoz E; de la Vega L
    Redox Biol; 2020 Oct; 37():101689. PubMed ID: 32863231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.